Fahreza Akbar Siregar, Cipto Mangunkusumo and Gurmeet Singh
Universitas Indonesia, Jakarta
National Central General Hospital, Jakarta
Scientific Tracks Abstracts: J Pulm Respir Med
Introduction & Objective: Community-Acquired Pneumonia (CAP) is one of the top leading causes of morbidity and
mortality worldwide. CAP also becomes the sixth most prevalent cause of overall mortality in adults. Corticosteroids are
known to be the most potent anti-inflammatory drugs and have physiologic rationale for their use in patients with infection.
Its efficacy in the treatment of CAP is still debatable. The objective is study to evaluate the efficacy and clinical outcomes of
systemic and inhaled steroid therapy for patients with community-acquired pneumonia.
Method: We used four databases for literature searching process, Pubmed, EBSCO, ProQuest and Science Direct, which
selected articles are those therapeutic studies with relevant clinical question and met the inclusion-exclusion criteriaâ??s. Critical
appraisal was performed by assessed its validity, importance, and applicability based on Oxford Center of Evidenced-Based
Medicine 2011.
Results: Three retrieved articles feature cohort studies. Two studies conducted systemic steroid therapy research which other
conducted inhaled steroid. Two of three articles show steroid therapy was associated with lower mortality and shorter clinical
stability.
Conclusion: We suggested that steroid therapy, both systemic and inhaled steroids help hasten clinical recovery, prevent
pneumonia-related complication, lower mortality and reduction in the duration of mechanical ventilation and length of
hospital stay.
Fahreza Akbar Siregar is currently pursuing his Medicine and also working as Clinical Co-assistant in Dr. Cipto Mangunkusumo National General Hospital (RSCM) Jakarta.
E-mail: fahreza_akbar@hotmail.com
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 